Goff DC - Search Results

1

Predicting relapse in schizophrenia: Is BDNF a plausible biological marker?

Pillai A, Schooler NR, Peter D, Looney SW, Goff DC, Kopelowicz A, Lauriello J, Manschreck T, Mendelowitz A, Miller DD, Severe JB, Wilson DR, Ames D, Bustillo J, Kane JM, Buckley PF. Pillai A, et al. Among authors: goff dc. Schizophr Res. 2018 Mar;193:263-268. doi: 10.1016/j.schres.2017.06.059. Epub 2017 Jul 19. Schizophr Res. 2018. PMID: 28734907

2

Cognitive therapy for psychosis in schizophrenia: an effect size analysis.

Gould RA, Mueser KT, Bolton E, Mays V, Goff D. Gould RA, et al. Schizophr Res. 2001 Mar 30;48(2-3):335-42. doi: 10.1016/s0920-9964(00)00145-6. Schizophr Res. 2001. PMID: 11295385

3

D-Cycloserine added to risperidone in patients with primary negative symptoms of schizophrenia.

Evins AE, Amico E, Posever TA, Toker R, Goff DC. Evins AE, et al. Among authors: goff dc. Schizophr Res. 2002 Jul 1;56(1-2):19-23. doi: 10.1016/s0920-9964(01)00220-1. Schizophr Res. 2002. PMID: 12084415 Clinical Trial.

4

Anterior and posterior hippocampal volumes in schizophrenia.

Weiss AP, Dewitt I, Goff D, Ditman T, Heckers S. Weiss AP, et al. Schizophr Res. 2005 Feb 1;73(1):103-12. doi: 10.1016/j.schres.2004.05.018. Schizophr Res. 2005. PMID: 15567082

5

Obsessive-compulsive symptoms in schizophrenia: associated clinical features, cognitive function and medication status.

Ongür D, Goff DC. Ongür D, et al. Among authors: goff dc. Schizophr Res. 2005 Jun 15;75(2-3):349-62. doi: 10.1016/j.schres.2004.08.012. Schizophr Res. 2005. PMID: 15885526 Review.

6

A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls.

Goff DC, Sullivan LM, McEvoy JP, Meyer JM, Nasrallah HA, Daumit GL, Lamberti S, D'Agostino RB, Stroup TS, Davis S, Lieberman JA. Goff DC, et al. Schizophr Res. 2005 Dec 1;80(1):45-53. doi: 10.1016/j.schres.2005.08.010. Epub 2005 Sep 28. Schizophr Res. 2005. PMID: 16198088 Clinical Trial.

7

The misattribution of salience in delusional patients with schizophrenia.

Holt DJ, Titone D, Long LS, Goff DC, Cather C, Rauch SL, Judge A, Kuperberg GR. Holt DJ, et al. Among authors: goff dc. Schizophr Res. 2006 Apr;83(2-3):247-56. doi: 10.1016/j.schres.2005.12.858. Epub 2006 Mar 15. Schizophr Res. 2006. PMID: 16540291 Clinical Trial.

8

Higher fasting serum insulin levels are associated with a better psychopathology profile in acutely ill non-diabetic inpatients with schizophrenia.

Fan X, Liu E, Pristach C, Goff DC, Henderson DC. Fan X, et al. Among authors: goff dc. Schizophr Res. 2006 Sep;86(1-3):30-5. doi: 10.1016/j.schres.2006.04.010. Epub 2006 Jun 5. Schizophr Res. 2006. PMID: 16750348

9

Risperidone augmentation for schizophrenia partially responsive to clozapine: a double-blind, placebo-controlled trial.

Freudenreich O, Henderson DC, Walsh JP, Culhane MA, Goff DC. Freudenreich O, et al. Among authors: goff dc. Schizophr Res. 2007 May;92(1-3):90-4. doi: 10.1016/j.schres.2006.12.030. Epub 2007 Feb 23. Schizophr Res. 2007. PMID: 17321111 Clinical Trial.

10

A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia.

Goff DC, Lamberti JS, Leon AC, Green MF, Miller AL, Patel J, Manschreck T, Freudenreich O, Johnson SA. Goff DC, et al. Neuropsychopharmacology. 2008 Feb;33(3):465-72. doi: 10.1038/sj.npp.1301444. Epub 2007 May 9. Neuropsychopharmacology. 2008. PMID: 17487227 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

581 results

Search Page